| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryo, Mammalian | 33 | 2022 | 464 | 4.850 |
Why?
|
| Embryonic Development | 15 | 2023 | 222 | 2.960 |
Why?
|
| Microscopy, Confocal | 20 | 2016 | 366 | 2.280 |
Why?
|
| Imaging, Three-Dimensional | 13 | 2024 | 395 | 2.160 |
Why?
|
| Mice | 103 | 2025 | 18944 | 1.690 |
Why?
|
| Tomography, Optical Coherence | 14 | 2021 | 567 | 1.560 |
Why?
|
| Yolk Sac | 7 | 2022 | 20 | 1.390 |
Why?
|
| X-Ray Microtomography | 7 | 2023 | 95 | 1.370 |
Why?
|
| Developmental Biology | 4 | 2011 | 15 | 1.330 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2016 | 615 | 1.300 |
Why?
|
| Luminescent Proteins | 13 | 2018 | 166 | 1.280 |
Why?
|
| Cardiovascular System | 5 | 2012 | 109 | 1.270 |
Why?
|
| Animals | 123 | 2025 | 36416 | 1.220 |
Why?
|
| Heart | 10 | 2018 | 749 | 1.130 |
Why?
|
| Microscopy, Fluorescence | 8 | 2021 | 336 | 1.060 |
Why?
|
| Endothelial Cells | 14 | 2022 | 544 | 1.030 |
Why?
|
| Microvessels | 5 | 2025 | 63 | 0.890 |
Why?
|
| Emergencies | 2 | 2016 | 185 | 0.890 |
Why?
|
| Genes, Lethal | 4 | 2022 | 77 | 0.870 |
Why?
|
| Time-Lapse Imaging | 2 | 2014 | 8 | 0.820 |
Why?
|
| Gene Editing | 5 | 2024 | 213 | 0.790 |
Why?
|
| Genes, Essential | 3 | 2024 | 43 | 0.780 |
Why?
|
| Mice, Knockout | 23 | 2025 | 3991 | 0.750 |
Why?
|
| Phenotype | 23 | 2025 | 4551 | 0.740 |
Why?
|
| Green Fluorescent Proteins | 12 | 2021 | 402 | 0.680 |
Why?
|
| Blood Vessels | 6 | 2014 | 108 | 0.670 |
Why?
|
| Iodine Compounds | 1 | 2019 | 2 | 0.640 |
Why?
|
| Contrast Media | 3 | 2019 | 513 | 0.600 |
Why?
|
| Fluorescence | 3 | 2013 | 103 | 0.570 |
Why?
|
| Mice, Transgenic | 19 | 2020 | 2529 | 0.540 |
Why?
|
| Blood Flow Velocity | 3 | 2009 | 468 | 0.530 |
Why?
|
| Ependyma | 2 | 2013 | 7 | 0.500 |
Why?
|
| Hemodynamics | 6 | 2018 | 872 | 0.490 |
Why?
|
| CRISPR-Cas Systems | 4 | 2024 | 295 | 0.480 |
Why?
|
| Abdomen | 1 | 2016 | 133 | 0.480 |
Why?
|
| Neovascularization, Physiologic | 7 | 2015 | 228 | 0.480 |
Why?
|
| Hydrogels | 6 | 2016 | 109 | 0.480 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 152 | 0.470 |
Why?
|
| Adult Stem Cells | 2 | 2013 | 54 | 0.470 |
Why?
|
| Patient Care Bundles | 1 | 2015 | 24 | 0.470 |
Why?
|
| Embryo, Nonmammalian | 4 | 2021 | 151 | 0.460 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2009 | 68 | 0.460 |
Why?
|
| Retina | 3 | 2025 | 502 | 0.450 |
Why?
|
| Laparotomy | 1 | 2015 | 142 | 0.440 |
Why?
|
| Patient Care Planning | 1 | 2015 | 134 | 0.440 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 847 | 0.440 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 6 | 2018 | 63 | 0.440 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2021 | 1046 | 0.440 |
Why?
|
| Postoperative Care | 1 | 2016 | 310 | 0.430 |
Why?
|
| Staining and Labeling | 5 | 2022 | 187 | 0.430 |
Why?
|
| Morphogenesis | 5 | 2018 | 215 | 0.420 |
Why?
|
| Image Enhancement | 2 | 2005 | 171 | 0.410 |
Why?
|
| Gap Junctions | 1 | 2013 | 45 | 0.400 |
Why?
|
| Automation | 1 | 2013 | 62 | 0.400 |
Why?
|
| Serum | 2 | 2011 | 46 | 0.400 |
Why?
|
| Connexins | 1 | 2013 | 65 | 0.400 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 58 | 0.390 |
Why?
|
| Corpus Striatum | 1 | 2013 | 97 | 0.390 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 84 | 0.390 |
Why?
|
| Biomimetic Materials | 4 | 2015 | 14 | 0.390 |
Why?
|
| Culture Media | 2 | 2011 | 184 | 0.390 |
Why?
|
| Zebrafish | 5 | 2021 | 419 | 0.380 |
Why?
|
| Myocardium | 6 | 2024 | 1045 | 0.380 |
Why?
|
| Embryo Culture Techniques | 3 | 2015 | 25 | 0.380 |
Why?
|
| Fluorescent Dyes | 4 | 2024 | 270 | 0.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2024 | 624 | 0.370 |
Why?
|
| Cell Membrane | 3 | 2015 | 487 | 0.360 |
Why?
|
| Myocardial Contraction | 3 | 2006 | 271 | 0.350 |
Why?
|
| Astrocytes | 2 | 2013 | 272 | 0.340 |
Why?
|
| Genetic Vectors | 3 | 2025 | 970 | 0.340 |
Why?
|
| Microscopy | 3 | 2017 | 123 | 0.340 |
Why?
|
| Specimen Handling | 1 | 2011 | 148 | 0.340 |
Why?
|
| Osteoporosis | 2 | 2021 | 140 | 0.320 |
Why?
|
| Embryo Implantation | 3 | 2023 | 234 | 0.320 |
Why?
|
| Mammals | 4 | 2023 | 280 | 0.320 |
Why?
|
| Microscopy, Video | 3 | 2010 | 20 | 0.320 |
Why?
|
| Genome | 3 | 2023 | 526 | 0.320 |
Why?
|
| Quality Improvement | 1 | 2015 | 692 | 0.310 |
Why?
|
| Diagnostic Imaging | 4 | 2013 | 317 | 0.310 |
Why?
|
| Zebrafish Proteins | 3 | 1995 | 129 | 0.300 |
Why?
|
| Myosin Light Chains | 3 | 2015 | 18 | 0.300 |
Why?
|
| Coronary Vessels | 2 | 2013 | 566 | 0.300 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 3 | 2014 | 42 | 0.290 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2015 | 446 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2008 | 234 | 0.280 |
Why?
|
| Blood Circulation | 1 | 2007 | 20 | 0.280 |
Why?
|
| Macrophages | 3 | 2018 | 703 | 0.280 |
Why?
|
| Cornea | 5 | 2025 | 594 | 0.280 |
Why?
|
| Coronary Circulation | 1 | 2008 | 219 | 0.280 |
Why?
|
| Computational Biology | 1 | 2013 | 887 | 0.280 |
Why?
|
| Algorithms | 6 | 2013 | 1730 | 0.280 |
Why?
|
| Embryo Loss | 3 | 2017 | 26 | 0.270 |
Why?
|
| Mutation | 6 | 2023 | 6294 | 0.270 |
Why?
|
| Skin | 2 | 2011 | 548 | 0.270 |
Why?
|
| Chick Embryo | 4 | 2018 | 130 | 0.270 |
Why?
|
| Disease | 2 | 2020 | 133 | 0.270 |
Why?
|
| Penetrance | 2 | 2017 | 111 | 0.260 |
Why?
|
| Capillaries | 2 | 2025 | 71 | 0.260 |
Why?
|
| Organogenesis | 3 | 2023 | 83 | 0.260 |
Why?
|
| Culture Techniques | 2 | 2003 | 82 | 0.250 |
Why?
|
| Humans | 51 | 2025 | 133547 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 12 | 2024 | 4841 | 0.250 |
Why?
|
| Artifacts | 2 | 2005 | 112 | 0.250 |
Why?
|
| Signal Transduction | 10 | 2017 | 4908 | 0.250 |
Why?
|
| Bone Density | 2 | 2020 | 374 | 0.240 |
Why?
|
| Microscopic Angioscopy | 1 | 2025 | 1 | 0.240 |
Why?
|
| Female | 33 | 2025 | 71537 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2018 | 161 | 0.240 |
Why?
|
| Rats | 7 | 2012 | 3882 | 0.240 |
Why?
|
| Nails | 1 | 2025 | 21 | 0.230 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2025 | 10 | 0.230 |
Why?
|
| Fetal Development | 1 | 2006 | 135 | 0.230 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2024 | 20 | 0.230 |
Why?
|
| Stem Cells | 3 | 2018 | 752 | 0.230 |
Why?
|
| Cell Movement | 8 | 2015 | 917 | 0.230 |
Why?
|
| Pregnancy | 10 | 2022 | 7528 | 0.230 |
Why?
|
| Animals, Newborn | 3 | 2019 | 1043 | 0.230 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4791 | 0.230 |
Why?
|
| Plasmids | 3 | 2021 | 526 | 0.220 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.220 |
Why?
|
| Cell Differentiation | 9 | 2018 | 2025 | 0.220 |
Why?
|
| Microcirculation | 1 | 2025 | 117 | 0.220 |
Why?
|
| Vascular Remodeling | 2 | 2022 | 53 | 0.220 |
Why?
|
| Models, Cardiovascular | 4 | 2011 | 190 | 0.220 |
Why?
|
| Central Nervous System | 3 | 1995 | 286 | 0.220 |
Why?
|
| Lymphangiogenesis | 2 | 2015 | 18 | 0.220 |
Why?
|
| Eye | 3 | 2023 | 245 | 0.220 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 112 | 0.220 |
Why?
|
| Mortality | 2 | 2016 | 262 | 0.220 |
Why?
|
| Eye Proteins | 1 | 2025 | 233 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 1161 | 0.210 |
Why?
|
| Dependovirus | 1 | 2025 | 151 | 0.210 |
Why?
|
| Polyethylene Glycols | 5 | 2012 | 253 | 0.210 |
Why?
|
| Macular Degeneration | 1 | 2025 | 127 | 0.210 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2024 | 216 | 0.200 |
Why?
|
| Synapses | 2 | 2024 | 468 | 0.200 |
Why?
|
| Ciliopathies | 1 | 2022 | 10 | 0.200 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2023 | 63 | 0.200 |
Why?
|
| Anophthalmos | 1 | 2023 | 24 | 0.200 |
Why?
|
| Coloboma | 1 | 2023 | 42 | 0.200 |
Why?
|
| Adenocarcinoma | 3 | 2015 | 1070 | 0.200 |
Why?
|
| Microphthalmos | 1 | 2023 | 58 | 0.200 |
Why?
|
| Tissue Engineering | 3 | 2015 | 184 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2022 | 78 | 0.200 |
Why?
|
| Electroporation | 1 | 2002 | 34 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2021 | 809 | 0.190 |
Why?
|
| Eye Abnormalities | 1 | 2023 | 102 | 0.190 |
Why?
|
| Transformation, Bacterial | 1 | 2021 | 11 | 0.190 |
Why?
|
| Chlamydia trachomatis | 1 | 2021 | 27 | 0.190 |
Why?
|
| Intellectual Disability | 2 | 2021 | 1078 | 0.190 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 288 | 0.190 |
Why?
|
| Time Factors | 9 | 2018 | 6581 | 0.190 |
Why?
|
| Nociception | 1 | 2021 | 14 | 0.190 |
Why?
|
| Chlamydia Infections | 1 | 2021 | 49 | 0.180 |
Why?
|
| Chromosomes, Bacterial | 1 | 2021 | 65 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 15 | 0.180 |
Why?
|
| Mice, Mutant Strains | 3 | 2013 | 400 | 0.180 |
Why?
|
| Coatomer Protein | 1 | 2021 | 31 | 0.180 |
Why?
|
| Gene Knockout Techniques | 2 | 2022 | 138 | 0.180 |
Why?
|
| Integrases | 2 | 2020 | 163 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 25 | 0.180 |
Why?
|
| Protein Interaction Maps | 2 | 2020 | 89 | 0.180 |
Why?
|
| Biological Evolution | 1 | 2022 | 256 | 0.180 |
Why?
|
| Neurons | 4 | 2024 | 2041 | 0.180 |
Why?
|
| Transfection | 2 | 2002 | 1090 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 139 | 0.170 |
Why?
|
| Ossification, Heterotopic | 2 | 2011 | 40 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2011 | 88 | 0.170 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2020 | 17 | 0.170 |
Why?
|
| Plants, Genetically Modified | 1 | 2020 | 45 | 0.170 |
Why?
|
| Animal Husbandry | 1 | 2020 | 10 | 0.170 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2018 | 411 | 0.170 |
Why?
|
| Tarsal Bones | 1 | 2020 | 3 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 74 | 0.170 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2015 | 53 | 0.170 |
Why?
|
| Neural Crest | 2 | 2015 | 56 | 0.170 |
Why?
|
| Aorta, Thoracic | 2 | 2018 | 538 | 0.170 |
Why?
|
| Optogenetics | 1 | 2020 | 76 | 0.160 |
Why?
|
| Genotype | 3 | 2021 | 2805 | 0.160 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 584 | 0.160 |
Why?
|
| Sezary Syndrome | 1 | 2019 | 14 | 0.160 |
Why?
|
| Mycosis Fungoides | 1 | 2019 | 15 | 0.160 |
Why?
|
| Osteoblasts | 1 | 2020 | 164 | 0.160 |
Why?
|
| Arabidopsis | 1 | 2020 | 94 | 0.160 |
Why?
|
| Peptides | 3 | 2017 | 860 | 0.160 |
Why?
|
| Cells, Cultured | 9 | 2019 | 3173 | 0.160 |
Why?
|
| Population Health | 1 | 2020 | 41 | 0.160 |
Why?
|
| Internationality | 1 | 2020 | 138 | 0.160 |
Why?
|
| Fibroblasts | 4 | 2021 | 921 | 0.160 |
Why?
|
| Sex Characteristics | 2 | 2020 | 335 | 0.160 |
Why?
|
| Phosphoproteins | 2 | 2015 | 456 | 0.160 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 115 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2015 | 178 | 0.150 |
Why?
|
| Male | 24 | 2025 | 65791 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2021 | 309 | 0.150 |
Why?
|
| Nitrous Oxide | 1 | 2018 | 13 | 0.150 |
Why?
|
| Adventitia | 1 | 2018 | 6 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 63 | 0.150 |
Why?
|
| Erythroid Precursor Cells | 1 | 2018 | 24 | 0.150 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2018 | 16 | 0.150 |
Why?
|
| Pericytes | 3 | 2013 | 24 | 0.150 |
Why?
|
| Genes, Reporter | 7 | 2018 | 395 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 67 | 0.150 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 46 | 0.150 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 36 | 0.150 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 71 | 0.150 |
Why?
|
| Pain | 1 | 2021 | 482 | 0.150 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 77 | 0.140 |
Why?
|
| Embryonic Induction | 2 | 1995 | 18 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2015 | 19 | 0.140 |
Why?
|
| Methacrylates | 1 | 2017 | 18 | 0.140 |
Why?
|
| Gelatin | 1 | 2017 | 17 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2023 | 1004 | 0.140 |
Why?
|
| International Cooperation | 2 | 2021 | 168 | 0.140 |
Why?
|
| Coculture Techniques | 5 | 2018 | 246 | 0.140 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 1762 | 0.140 |
Why?
|
| DNA Damage | 2 | 2019 | 545 | 0.140 |
Why?
|
| Genetic Engineering | 2 | 2024 | 164 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2018 | 2554 | 0.140 |
Why?
|
| Mesoderm | 1 | 2017 | 113 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 1310 | 0.130 |
Why?
|
| Reproducibility of Results | 6 | 2022 | 3029 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 111 | 0.130 |
Why?
|
| Software | 2 | 2020 | 735 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 190 | 0.130 |
Why?
|
| Tomography, Optical | 1 | 2016 | 8 | 0.130 |
Why?
|
| Sequence Homology | 1 | 2016 | 63 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 876 | 0.130 |
Why?
|
| Iodine | 1 | 2016 | 23 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 118 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2019 | 482 | 0.130 |
Why?
|
| Organ of Corti | 1 | 2016 | 26 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 733 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1995 | 616 | 0.130 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 24 | 0.130 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2015 | 7 | 0.130 |
Why?
|
| Whey Proteins | 1 | 2015 | 7 | 0.120 |
Why?
|
| Photons | 2 | 2009 | 53 | 0.120 |
Why?
|
| Ear, Inner | 1 | 2016 | 50 | 0.120 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2016 | 63 | 0.120 |
Why?
|
| Whole Body Imaging | 1 | 2016 | 31 | 0.120 |
Why?
|
| Kidney | 3 | 2020 | 1418 | 0.120 |
Why?
|
| Hematocrit | 2 | 2007 | 116 | 0.120 |
Why?
|
| Conserved Sequence | 1 | 2016 | 300 | 0.120 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2016 | 42 | 0.120 |
Why?
|
| Decidua | 1 | 2016 | 142 | 0.120 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ectoderm | 1 | 1995 | 32 | 0.120 |
Why?
|
| Femur | 1 | 2015 | 75 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 2 | 2015 | 336 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 112 | 0.120 |
Why?
|
| Models, Organizational | 1 | 2015 | 43 | 0.120 |
Why?
|
| Hearing Loss | 1 | 2017 | 214 | 0.120 |
Why?
|
| Corneal Neovascularization | 1 | 2015 | 13 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 30 | 0.120 |
Why?
|
| Tissue Embedding | 1 | 2014 | 4 | 0.120 |
Why?
|
| Sepharose | 1 | 2014 | 14 | 0.120 |
Why?
|
| Corneal Injuries | 1 | 2015 | 36 | 0.120 |
Why?
|
| Pupil | 1 | 2015 | 57 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2009 | 831 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2015 | 197 | 0.110 |
Why?
|
| Skull | 1 | 2015 | 146 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 509 | 0.110 |
Why?
|
| Face | 1 | 2015 | 189 | 0.110 |
Why?
|
| Collagen | 1 | 2015 | 327 | 0.110 |
Why?
|
| Models, Biological | 3 | 2015 | 1535 | 0.110 |
Why?
|
| Cell Nucleus | 4 | 2010 | 688 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2015 | 191 | 0.110 |
Why?
|
| Genome, Human | 1 | 2021 | 1348 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1102 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 274 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 1782 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2016 | 468 | 0.110 |
Why?
|
| Implants, Experimental | 2 | 2010 | 7 | 0.110 |
Why?
|
| Survival Rate | 2 | 2016 | 2217 | 0.110 |
Why?
|
| Integrin beta1 | 2 | 2010 | 56 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2018 | 521 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 201 | 0.100 |
Why?
|
| Wnt Proteins | 4 | 2015 | 223 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 674 | 0.100 |
Why?
|
| Mitosis | 2 | 2010 | 195 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 1868 | 0.100 |
Why?
|
| Brain | 4 | 2024 | 3225 | 0.100 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2012 | 29 | 0.100 |
Why?
|
| Mutagenesis | 3 | 2023 | 355 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 206 | 0.100 |
Why?
|
| Intracranial Hypotension | 1 | 2012 | 11 | 0.100 |
Why?
|
| Retinoscopes | 1 | 2012 | 5 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 246 | 0.100 |
Why?
|
| Nanotubes, Carbon | 1 | 2012 | 20 | 0.100 |
Why?
|
| SOXF Transcription Factors | 1 | 2012 | 18 | 0.100 |
Why?
|
| Education | 1 | 2013 | 112 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 589 | 0.100 |
Why?
|
| Vertebrates | 1 | 1992 | 40 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 148 | 0.100 |
Why?
|
| Retinal Vessels | 2 | 2011 | 84 | 0.100 |
Why?
|
| Amelogenesis | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tooth Calcification | 1 | 2012 | 3 | 0.100 |
Why?
|
| Gestational Age | 1 | 2016 | 1216 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 82 | 0.100 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2012 | 29 | 0.100 |
Why?
|
| Methotrexate | 1 | 2014 | 354 | 0.090 |
Why?
|
| Dental Enamel | 1 | 2012 | 20 | 0.090 |
Why?
|
| In Situ Hybridization | 4 | 2011 | 484 | 0.090 |
Why?
|
| Indoles | 1 | 2013 | 202 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1067 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 902 | 0.090 |
Why?
|
| Neurogenic Inflammation | 1 | 2011 | 4 | 0.090 |
Why?
|
| Alleles | 3 | 2024 | 1709 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 1621 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 356 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2655 | 0.090 |
Why?
|
| Pyrroles | 1 | 2013 | 187 | 0.090 |
Why?
|
| Ephrin-A1 | 1 | 2011 | 2 | 0.090 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2014 | 217 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2018 | 1604 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 352 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2011 | 26 | 0.090 |
Why?
|
| Calcium | 2 | 2024 | 1146 | 0.090 |
Why?
|
| Retinoblastoma | 1 | 2012 | 117 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2011 | 481 | 0.090 |
Why?
|
| Retinal Neoplasms | 1 | 2012 | 103 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 219 | 0.090 |
Why?
|
| Hematopoiesis | 2 | 2010 | 230 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 976 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 63 | 0.090 |
Why?
|
| Immobilized Proteins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2016 | 868 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 267 | 0.090 |
Why?
|
| Receptors, Laminin | 1 | 2010 | 3 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 161 | 0.090 |
Why?
|
| Neurogenesis | 1 | 2013 | 223 | 0.090 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2010 | 11 | 0.090 |
Why?
|
| Focal Adhesions | 1 | 2010 | 14 | 0.090 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2010 | 45 | 0.090 |
Why?
|
| Mitochondria | 1 | 2016 | 744 | 0.080 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2010 | 37 | 0.080 |
Why?
|
| Length of Stay | 1 | 2016 | 1384 | 0.080 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2010 | 94 | 0.080 |
Why?
|
| Schizosaccharomyces | 1 | 2010 | 66 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 79 | 0.080 |
Why?
|
| Transplantation | 1 | 2010 | 27 | 0.080 |
Why?
|
| Cartilage | 1 | 2010 | 51 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2011 | 104 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 132 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2010 | 38 | 0.080 |
Why?
|
| Placentation | 1 | 2010 | 61 | 0.080 |
Why?
|
| Gene Expression | 5 | 2001 | 1616 | 0.080 |
Why?
|
| Endocytosis | 1 | 2010 | 133 | 0.080 |
Why?
|
| Wnt1 Protein | 3 | 1995 | 73 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 263 | 0.080 |
Why?
|
| Transgenes | 3 | 2025 | 346 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 128 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 55 | 0.080 |
Why?
|
| Transduction, Genetic | 2 | 2025 | 296 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 791 | 0.080 |
Why?
|
| Antioxidants | 1 | 2012 | 377 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2010 | 74 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 381 | 0.080 |
Why?
|
| Actins | 2 | 2010 | 350 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 69 | 0.080 |
Why?
|
| Blood Cells | 1 | 2009 | 55 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 250 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 474 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 664 | 0.080 |
Why?
|
| Endocardium | 1 | 2009 | 56 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 177 | 0.080 |
Why?
|
| Lasers | 1 | 2009 | 115 | 0.080 |
Why?
|
| Fetal Heart | 1 | 2010 | 136 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 406 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 1 | 2009 | 87 | 0.070 |
Why?
|
| Merkel Cells | 1 | 2008 | 5 | 0.070 |
Why?
|
| Hypotonic Solutions | 1 | 2008 | 14 | 0.070 |
Why?
|
| Optics and Photonics | 1 | 2009 | 123 | 0.070 |
Why?
|
| Movement | 2 | 2009 | 178 | 0.070 |
Why?
|
| Endothelium | 1 | 2008 | 71 | 0.070 |
Why?
|
| Genetic Therapy | 2 | 2025 | 733 | 0.070 |
Why?
|
| Lipids | 2 | 2002 | 566 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 2163 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 991 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2015 | 362 | 0.070 |
Why?
|
| Erythroblasts | 1 | 2007 | 5 | 0.070 |
Why?
|
| Arteries | 2 | 2022 | 230 | 0.070 |
Why?
|
| Blood Viscosity | 1 | 2007 | 13 | 0.070 |
Why?
|
| Shear Strength | 1 | 2007 | 16 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 2024 | 281 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2012 | 2712 | 0.070 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2022 | 94 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2018 | 905 | 0.070 |
Why?
|
| Cell Communication | 1 | 2008 | 187 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 3 | 2016 | 127 | 0.070 |
Why?
|
| Hemorrhage | 2 | 2025 | 507 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 93 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2008 | 165 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2936 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 834 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1350 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2012 | 722 | 0.070 |
Why?
|
| Testis | 1 | 2009 | 433 | 0.070 |
Why?
|
| DNA Repair | 1 | 2010 | 631 | 0.070 |
Why?
|
| Equipment Design | 3 | 2016 | 604 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 202 | 0.060 |
Why?
|
| Exons | 2 | 2020 | 833 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2018 | 836 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2008 | 255 | 0.060 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 274 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 522 | 0.060 |
Why?
|
| Cell Lineage | 3 | 2016 | 369 | 0.060 |
Why?
|
| Nervous System | 1 | 2006 | 131 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2006 | 171 | 0.060 |
Why?
|
| Placenta | 1 | 2010 | 535 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2024 | 869 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2006 | 126 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2022 | 704 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 3088 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2013 | 1134 | 0.060 |
Why?
|
| Serogroup | 1 | 2025 | 63 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2025 | 400 | 0.060 |
Why?
|
| Schools, Medical | 1 | 2025 | 125 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2024 | 199 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 1327 | 0.050 |
Why?
|
| Cell Line | 3 | 2017 | 2840 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3166 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2003 | 38 | 0.050 |
Why?
|
| Research Personnel | 1 | 2025 | 135 | 0.050 |
Why?
|
| Phalloidine | 1 | 2003 | 2 | 0.050 |
Why?
|
| Optical Imaging | 1 | 2024 | 74 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1874 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2003 | 122 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2022 | 1241 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2015 | 109 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 126 | 0.050 |
Why?
|
| Air | 1 | 2002 | 26 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2023 | 321 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 14804 | 0.050 |
Why?
|
| Receptors, Nicotinic | 1 | 2003 | 159 | 0.050 |
Why?
|
| Homozygote | 2 | 2022 | 561 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 136 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 46 | 0.050 |
Why?
|
| Biomechanical Phenomena | 2 | 2018 | 260 | 0.050 |
Why?
|
| Nicotine | 1 | 2003 | 147 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 1418 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1917 | 0.050 |
Why?
|
| Proteins | 2 | 2020 | 1093 | 0.050 |
Why?
|
| Cilia | 1 | 2022 | 78 | 0.050 |
Why?
|
| Temperature | 1 | 2002 | 329 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2021 | 27 | 0.050 |
Why?
|
| Microinjections | 1 | 2001 | 51 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2010 | 801 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 568 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 82 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 96 | 0.040 |
Why?
|
| Cadherins | 1 | 2002 | 186 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 130 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 36 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 26 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2020 | 55 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2012 | 87 | 0.040 |
Why?
|
| Base Sequence | 3 | 2012 | 3171 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2006 | 992 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 2789 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3843 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 228 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 133 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 3479 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 368 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 785 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 433 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 934 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 365 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 714 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2297 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 92 | 0.040 |
Why?
|
| Genes | 1 | 2020 | 450 | 0.040 |
Why?
|
| Ventricular Myosins | 1 | 2018 | 4 | 0.040 |
Why?
|
| Immunomagnetic Separation | 1 | 2018 | 12 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 198 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 863 | 0.040 |
Why?
|
| Antigens, Ly | 1 | 2018 | 35 | 0.040 |
Why?
|
| Drosophila | 1 | 2003 | 825 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1439 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 78 | 0.040 |
Why?
|
| Troponin | 1 | 2018 | 78 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 111 | 0.040 |
Why?
|
| Child | 4 | 2021 | 25761 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 1624 | 0.040 |
Why?
|
| Aged | 4 | 2025 | 21637 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 188 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 403 | 0.040 |
Why?
|
| Hearing Tests | 1 | 2017 | 16 | 0.040 |
Why?
|
| Apelin | 1 | 2017 | 2 | 0.040 |
Why?
|
| Apelin Receptors | 1 | 2017 | 2 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2018 | 177 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2018 | 195 | 0.040 |
Why?
|
| Vacuoles | 1 | 2017 | 29 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2017 | 24 | 0.030 |
Why?
|
| Genes, Modifier | 1 | 2017 | 17 | 0.030 |
Why?
|
| Lighting | 1 | 2017 | 19 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2017 | 39 | 0.030 |
Why?
|
| Cystectomy | 1 | 1998 | 164 | 0.030 |
Why?
|
| Aircraft | 1 | 2017 | 22 | 0.030 |
Why?
|
| Amino Acids | 1 | 2020 | 687 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 104 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 366 | 0.030 |
Why?
|
| Gels | 1 | 2017 | 72 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 292 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 3704 | 0.030 |
Why?
|
| Peptide Hormones | 1 | 2017 | 71 | 0.030 |
Why?
|
| Tail | 1 | 2016 | 15 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 123 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 250 | 0.030 |
Why?
|
| Microscopy, Acoustic | 1 | 2016 | 17 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 412 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 18 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 55 | 0.030 |
Why?
|
| Rotation | 1 | 2016 | 53 | 0.030 |
Why?
|
| Regeneration | 1 | 2018 | 231 | 0.030 |
Why?
|
| Extremities | 1 | 2016 | 88 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3736 | 0.030 |
Why?
|
| Biomimetics | 1 | 2015 | 18 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 122 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2015 | 33 | 0.030 |
Why?
|
| Wnt3 Protein | 1 | 1995 | 4 | 0.030 |
Why?
|
| Light | 1 | 2016 | 183 | 0.030 |
Why?
|
| Endoglin | 1 | 2015 | 30 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 1995 | 27 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2015 | 7 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 29254 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 3429 | 0.030 |
Why?
|
| Mandible | 1 | 2015 | 82 | 0.030 |
Why?
|
| Alkalies | 1 | 2015 | 25 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3977 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 37 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2015 | 153 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1995 | 124 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 296 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 224 | 0.030 |
Why?
|
| Burns, Chemical | 1 | 2015 | 31 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 31830 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 258 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 166 | 0.030 |
Why?
|
| Spine | 1 | 1995 | 147 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 157 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 177 | 0.030 |
Why?
|
| Ifosfamide | 1 | 2014 | 35 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 85 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 3754 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 63 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cytarabine | 1 | 2014 | 100 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 120 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2014 | 136 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 20516 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 103 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2016 | 214 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1995 | 231 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 86 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 563 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 1136 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 105 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 162 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1558 | 0.030 |
Why?
|
| Prednisone | 1 | 2014 | 288 | 0.030 |
Why?
|
| Vincristine | 1 | 2014 | 196 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 229 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 199 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1596 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 399 | 0.030 |
Why?
|
| Rituximab | 1 | 2014 | 164 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 453 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1998 | 557 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1695 | 0.030 |
Why?
|
| DNA Primers | 1 | 1994 | 669 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 136 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 300 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 1037 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2015 | 276 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 426 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2014 | 281 | 0.020 |
Why?
|
| Cell Division | 1 | 1994 | 773 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 165 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 3970 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1994 | 319 | 0.020 |
Why?
|
| Acrylates | 1 | 2012 | 10 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 9869 | 0.020 |
Why?
|
| Tooth Diseases | 1 | 2012 | 3 | 0.020 |
Why?
|
| Hardness Tests | 1 | 2012 | 2 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 261 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 99 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2012 | 43 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 416 | 0.020 |
Why?
|
| Neural Tube Defects | 1 | 2015 | 358 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 24 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 972 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2173 | 0.020 |
Why?
|
| Cromolyn Sodium | 1 | 2011 | 5 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2012 | 98 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2012 | 59 | 0.020 |
Why?
|
| Substance P | 1 | 2011 | 38 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 889 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2015 | 830 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 239 | 0.020 |
Why?
|
| Diaphragm | 1 | 2012 | 99 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2011 | 62 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 1672 | 0.020 |
Why?
|
| TRPV Cation Channels | 1 | 2011 | 46 | 0.020 |
Why?
|
| Fractals | 1 | 2011 | 2 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2011 | 119 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 90 | 0.020 |
Why?
|
| Succinimides | 1 | 2010 | 7 | 0.020 |
Why?
|
| Carbonates | 1 | 2010 | 5 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 248 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2010 | 12 | 0.020 |
Why?
|
| Zyxin | 1 | 2010 | 5 | 0.020 |
Why?
|
| Dynamin II | 1 | 2010 | 2 | 0.020 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2010 | 14 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2010 | 26 | 0.020 |
Why?
|
| Clathrin | 1 | 2010 | 25 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2017 | 1094 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 1101 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1467 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 94 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 319 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 68 | 0.020 |
Why?
|
| Muscles | 1 | 2011 | 306 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1756 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 88 | 0.020 |
Why?
|
| Adipocytes, Brown | 1 | 2010 | 27 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 119 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2010 | 73 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 839 | 0.020 |
Why?
|
| Materials Testing | 1 | 2010 | 79 | 0.020 |
Why?
|
| Hair Follicle | 1 | 2010 | 35 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12997 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 231 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 2009 | 56 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 168 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 1079 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 645 | 0.020 |
Why?
|
| Sertoli Cells | 1 | 2009 | 80 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 5466 | 0.020 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2008 | 20 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1928 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 248 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2010 | 202 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 12 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 544 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 118 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 379 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2012 | 629 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1990 | 484 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1143 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1735 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 303 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1844 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 7181 | 0.020 |
Why?
|
| RNA | 1 | 1990 | 605 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 697 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2006 | 74 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 505 | 0.020 |
Why?
|
| Dishevelled Proteins | 1 | 2006 | 45 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 60 | 0.020 |
Why?
|
| Heterozygote | 1 | 2008 | 720 | 0.020 |
Why?
|
| Pressure | 1 | 2006 | 136 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11683 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8588 | 0.010 |
Why?
|
| Action Potentials | 1 | 2008 | 530 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 360 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 786 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 11101 | 0.010 |
Why?
|
| Aging | 2 | 2005 | 1300 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2898 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 72 | 0.010 |
Why?
|
| Chloride Channels | 1 | 2003 | 62 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 2987 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 180 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 174 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 300 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 789 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13172 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 2164 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 388 | 0.010 |
Why?
|
| Dendrites | 1 | 2003 | 204 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 2001 | 22 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 2001 | 39 | 0.010 |
Why?
|
| Disulfides | 1 | 2001 | 84 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 137 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 763 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 612 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 17401 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1995 | 80 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 192 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1995 | 170 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 1386 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 911 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 451 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1998 | 1313 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 125 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 397 | 0.010 |
Why?
|
| Liver | 1 | 1995 | 1878 | 0.000 |
Why?
|